Overall survival and progression-free survival from start of first-line and second-line IO and chemotherapy by <i>KRAS/STK11</i> mutation status (all patients).
收藏NIAID Data Ecosystem2026-03-12 收录
数据链接：
官方服务：
资源简介：
Overall survival and progression-free survival from start of first-line and second-line IO and chemotherapy by KRAS/STK11 mutation status (all patients).
创建时间：
2020-09-03
